Kalpataru Avenue

Project Overview

Kalpataru Avenue is a Commercial project developed by Neo Pharma Private Limited in Kandivali East, Mumbai Suburban district. The project is registered with MahaRERA under registration number P51800003417. The development is a single 12-floor commercial building — Kalpataru Avenue — with 105 non-residential (commercial) units, on a land area of approximately 0.412 acres (1,666 sq m) at CTS No. 134/F/1A (part) of Village Akurli, Akurli Road, Borivali taluka, Mumbai 400101. The sanctioned built-up area is 5,803.4 sq m with 362 sq m of recreational open space. The original RERA completion date was 30 June 2021, revised to 30 April 2022.

Note: This is a purely commercial project (105 non-residential units, 0 residential). Buyers seeking residential apartments should confirm the project scope before proceeding. The registered promoter is Neo Pharma Private Limited, with a registered address at Kalpataru Synergy, Vakola, Santacruz East, Mumbai — indicating a connection to the Kalpataru brand.

Location & Connectivity

Kandivali East is a northern Mumbai suburb in Borivali taluka, accessible from Akurli Road. The site fronts Akurli Road to the south and an 18m DP road to the west, with a municipal market plot as the eastern neighbour. Kandivali railway station (Western line) is the primary transit hub, offering fast access to Churchgate and Borivali.

Kandivali has grown significantly as a commercial and residential node, with several IT parks and SME clusters in the vicinity. The project's pin code is 400101.

Developer & Approvals

Neo Pharma Private Limited is the registered promoter — a special purpose or group company associated with the Kalpataru brand (as evidenced by the registered address at Kalpataru Synergy).

Approvals on record with MahaRERA:

• RERA Registration Certificate (P51800003417)
• Building Plan Sanction (Municipal Authority)
• Fire Safety NOC
• Environment Clearance / Consent to Establish
• Sewerage & Water Connection Approval

Configurations & Amenities

Kalpataru Avenue contains 105 commercial units spread across 12 floors (all non-residential). Unit sizes, configuration (shops vs. offices), and available tenancy types are not individually enumerated in the RERA filing. Buyers and investors should request the complete unit schedule and commercial usage approvals from Neo Pharma / Kalpataru's registered sales team.

The 362 sq m recreational open space allocation is mandatory under MCGM norms. Confirm service-level provisions (power backup, parking, lifts) from the RERA-filed facilities declaration.

Investment & Buyer Due Diligence

Pricing is on request. With the April 2022 revised completion date elapsed, due diligence for commercial buyers: (a) verify OC/CC on MahaRERA (P51800003417); (b) confirm permitted commercial use (office, retail, or mixed-use); (c) check BMC zoning and FSI compliance; (d) review Neo Pharma's legal standing and relationship to Kalpataru Group; (e) verify CTS No. 134/F/1A, Akurli village records; and (f) assess the Akurli Road commercial corridor's rental yield and vacancy rates for investment planning.